KHN’s ‘What the Health?’: Manchin Makes a Deal
In a rare surprise for official Washington, Senate Majority Leader Chuck Schumer and Sen. Joe Manchin (D-W.Va.) announced a deal to expand the planned health bill in the Senate to include provisions raising taxes and addressing climate change. The measure would include a third year of expanded subsidies for the Affordable Care Act, but not health care coverage for people left out of Medicaid in states that failed to expand the program. Meanwhile, the ACA goes back to court, and the Biden administration restores anti-discrimination protections for LGBTQ+ people that were rolled back by the Trump administration. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Céline Gounder of KHN about the latest on the monkeypox outbreak.
Lo que debes saber sobre Paxlovid para tratar covid, en especial, ¿debes tomarlo?
Desde que Paxlovid comenzó a estar disponible hace siete meses, ha eclipsado otras terapias disponibles para prevenir los síntomas graves de covid en pacientes de alto riesgo. Algunos médicos se apresuran a recetarlo, pero como ocurre con tanto sobre la pandemia de covid, hay controversia.
Everything You Need to Know About Paxlovid — Especially, Should You Take It?
Paxlovid has eclipsed other available therapies for preventing life-threatening covid symptoms in high-risk patients. But even as doctors praise its effectiveness, many say they have unanswered questions about prescribing the drug and want more and better data about it.
To Stem the Spread of Monkeypox, Health Departments Tap Into Networks of Those Most at Risk
Although the disease is currently spreading almost exclusively among men who have sex with men, some cases are turning up in other populations — and that number is likely to grow if public health officials don’t effectively nip the outbreak in the bud.
KHN’s ‘What the Health?’: Drug Price Bill Is a Go in the Senate
Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.
Critics Worry Government Surveillance of HIV May Hurt More Than It Helps
Some people living with HIV and some state health officials are raising concerns about part of the federal effort to end the HIV epidemic: a new technology that analyzes blood samples to find emerging outbreaks. The critics say it’s too invasive and stigmatizing and might not be more effective than older public health approaches.
Watch: Why the Public Health System Is Having Trouble Containing Monkeypox
KHN Midwest correspondent Lauren Weber appeared on CBS News’ streaming network to discuss “Fighting Monkeypox, Sexual Health Clinics Are Underfunded and Ill-Equipped,” an article she wrote with KHN senior correspondent Liz Szabo. It details how ill-equipped the nation’s sexual health clinics and public health system are to tackle monkeypox after decades of underfunding. Weber described […]
Las clínicas de salud sexual luchan sin medios contra la viruela del simio
Las clínicas que tratan las enfermedades de transmisión sexual —que ya se enfrentaban a un aumento explosivo de enfermedades como la sífilis y la gonorrea— se encuentran ahora en la primera línea de la lucha para controlar el brote de viruela del simio, que crece rápidamente.
Fighting Monkeypox, Sexual Health Clinics Are Underfunded and Ill-Equipped
Sexual health clinics are scrambling to properly track, test, and treat hundreds of monkeypox patients. So far, it isn’t going well.
¿Ponerse el refuerzo ahora o esperar? Muchos se preguntan cómo navegar la próxima ola de covid
Aproximadamente el 70% de los estadounidenses de 50 años o más que recibieron una primera vacuna de refuerzo contra covid, y casi la misma cantidad de personas de 65 años o más, no han recibido un segundo, según datos de los CDC.
Conservative Blocs Unleash Litigation to Curb Public Health Powers
Spurred on by opposition to pandemic-related health mandates, a coalition of religious liberty groups, conservative think tanks, and Republican state attorneys general has filed a cascade of litigation seeking to rein in the powers of public health authorities.
Boost Now or Wait? Many Wonder How Best to Ride Out Covid’s Next Wave
As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven’t received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others aren’t sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.
As Big Pharma Loses Interest in New Antibiotics, Infections Are Only Growing Stronger
Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.
California’s Public Health Tax Is Dead for the Year
A ballot measure that would have taxed California millionaires to boost public health funding will not be on the November ballot. But the tech titans who bankrolled the effort say they are negotiating with Gov. Gavin Newsom’s administration to get more money without imposing new taxes.
KHN’s ‘What the Health?’: Life After ‘Roe’ Is … Confusing
A rapidly changing landscape for abortion has left patients, providers, employers, and lawmakers alike wondering what is and is not legal and what to do next. Meanwhile, Democrats in Congress have resumed negotiations on legislation to lower drug prices and, potentially, continue expanded insurance subsidies for the Affordable Care Act. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
As California Welcomes Ukrainian Refugees, Counties Fall Short on Interpreters
As Ukrainians settle in California, many are tapping Medi-Cal. But in some counties, particularly Sacramento, the health department doesn’t have enough interpreters.
Las medidas de Colorado no sirven para frenar los altos niveles de ozono peligrosos para la salud
El ozono se crea cuando las sustancias químicas que se emiten a la atmósfera a través de los tubos de escape de los vehículos, la explotación de petróleo y gas y los incendios forestales se calientan con el sol. La contaminación por ozono es un problema persistente en la región.
Colorado’s Efforts Are Not Enough to Solve Its Ozone Problem
Some health experts said measures underway by state and federal officials won’t lower ozone pollution to safe levels across nine counties of Colorado’s Front Range.
Igual que con covid, atraso en pruebas y vacunas para la viruela del simio
Los casos de la viruela del simio siguen aumentando, pero la respuesta sanitaria es lenta: escasean las pruebas y las dosis de la vacuna que puede prevenir la infección.
Vaccine and Testing Delays for Monkeypox Echo Failures in Early Covid Response
Public health officials say monkeypox is not as dangerous as covid and can be handled well with current treatments and if those at risk use caution. But the rollout of vaccines has been slow and led to angst among some at-risk people.
